Definitive Contract 75N93023C00026
Award Date
9/15/23
Potential Completion Date
9/14/24
Potential Value
$298K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Sky Park Labs LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Concord, MA 01742, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $300,000 Firm Fixed Price Definitive Contract to L2 Diagnostics LLC, a small business, for the NOVEL DIAGNOSTIC BIOMARKERS DISCOVERY AND VALIDATION FOR MALARIA SBIR PHASE I effort. This Small Business Innovation Research (SBIR) Phase I contract has a performance period ending on November 30, 2025 and is set aside for total small business participation. L2 Diagnostics LLC is a for-profit limited...
This is a $299,208 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to John Snow Labs Inc., a self-certified small disadvantaged business. The contract is for SBIR Topic 135, with a period of performance through September 4, 2025. The contract does not have a set-aside designation. As an SBIR (Small Business Innovation Research) contract, it is part of a larger SBIR program managed by NIAID to fund research and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,576 Small Business Innovation Research (SBIR) Phase I contract to Gate Scientific, Inc., a for-profit manufacturer of advanced molecular diagnostic and testing technologies located in Milpitas, California. The contract is for the development of a disposal point-of-care HIV nucleic acid test, which was set aside for small businesses. This contract builds on Gate Scientific's expertise in developing innovative...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Insilicom LLC, a woman-owned, minority-owned small business. The contract is for SBIR (Small Business Innovation Research) Topic 136 - INSILICOM, which involves developing advanced artificial intelligence and knowledge graph technologies for biomedical research and applications. The contract has no set-aside designation and is focused on creating...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...
This firm fixed price definitive contract for $300,000 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Innov8Ai, a for-profit small business, to advance the agency's mission through research and development. The contract is associated with the Small Business Innovation Research Program Phase I solicitation to capture medical misinformation in social media for targeted interdiction using an...